National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
indium In 111 ibritumomab tiuxetan (IN-dee-um … ih-brih-TOO-moh-mab ty-oo-EKS-eh-tan)

 A radiolabeled monoclonal antibody that is used to detect certain types of B-cell non-Hodgkin lymphoma and is being studied in the detection of other types of B-cell tumors. It is made up of the monoclonal antibody ibritumomab plus the radioisotope indium 111. It binds to the protein called CD20, which is found on B cells. A machine is used to detect which cells in the body have bound the antibody. Indium In 111 ibritumomab tiuxetan is a type of radiopharmaceutical. Also called In 111 ibritumomab tiuxetan and In 111 Zevalin.

Previous Definitions:indication, indinavir, indirect ophthalmoscopy, indium In 111 CHX-A DTPA trastuzumab, indium In 111 DOTA monoclonal antibody HuAFP31
Next Definitions:indium In 111 pentetreotide, indole-3-carbinol, indolent, indolent lymphoma, indomethacin